BIIB vs EIX · P/E 21, rev $9.89B vs P/E 7.3, rev $17.60B
Biogen Inc (BIIB) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the BIIB and EIX stock pages for the full models.
Not investment advice.